Stanley Druckenmiller's WVE Position Overview
Stanley Druckenmiller (via Duquesne Family Office LLC) currently holds 173,000 shares of Wave Life Sciences Ltd. (WVE) worth $2.94 M, representing 0.07% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Stanley Druckenmiller has initiated a new position in WVE, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Stanley Druckenmiller's Wave Life Sciences (WVE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Wave Life Sciences (WVE) Trades by Stanley Druckenmiller
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +173,000 | New Buy | 173,000 | $17.00 |
Stanley Druckenmiller's Wave Life Sciences Investment FAQs
Stanley Druckenmiller first purchased Wave Life Sciences Ltd. (WVE) in Q4 2025, acquiring 173,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Stanley Druckenmiller has held Wave Life Sciences Ltd. (WVE) for 1 quarters since Q4 2025.
Stanley Druckenmiller's largest addition to Wave Life Sciences Ltd. (WVE) was in Q4 2025, adding 173,000 shares worth $2.94 M.
According to the latest 13F filing for Q4 2025, Stanley Druckenmiller's firm, Duquesne Family Office LLC, owns 173,000 shares of Wave Life Sciences Ltd. (WVE), valued at approximately $2.94 M.
As of the Q4 2025 filing, Wave Life Sciences Ltd. (WVE) represents approximately 0.07% of Stanley Druckenmiller's publicly disclosed stock portfolio, making it one of their key holdings.
Stanley Druckenmiller's peak holding in Wave Life Sciences Ltd. (WVE) was 173,000 shares, as reported at the end of Q4 2025.